Alexion says wholesale acquisition cost for Ultomiris set at $6,404 per vial

In a regulatory filing, Alexion stated that it has established a wholesale acquisition cost for Ultomiris in the United States of $6,404 per 30 mL of 10 mg/mL vial. “On an annual basis, this represents an approximate 10% discount to the cost of current labeled maintenance therapy for adult PNH patients of average weight,” Alexion stated.
https://thefly.com/landingPageNews.php?id=2840733